Ann: Appendix 4C & Quarterly Update, page-4

I've just emailed MT with regard to the payment to Healey. As they are a Hospital and a Clinical Trial provider they do require Funding Payments to cover their costs of Clinicians and Diagnostics for Biosamples , Data input and analysis etc.

I believe the cost is circa $10m but will wait for confirmation unless anyone else can demonstrate costs? I do believe it was mentioned last year at the AGM.

My understanding is we also require all of the Trial Medication including Placebo tablets to be produced prior to the Trial commencement as a form of Trial patient Protection, remember its a contract with a Trial Patient, they commit to the Trial Regime of Dosing frequency and attending clinics for Bloods , Urine etc plus NUZ deliver ongoing compassionate dose once the trial is completed.
That's why I thought NUZ were producing 750,000 tablets as the Trial is 2 x 9 month periods now across 120 plus Trial Patients. We ran out of 10mg tablets in the Phase I with 12 Patients and I believe Mollard had taken delivery of 75,000 for the initial trial..

I may be able to ask on the Investor Hub..NZT